AIP
AMRI

Ameritas Investment Partners’s Albany Molecular Research Inc AMRI Stock Holding History

Ameritas Investment Partners’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,006
Closed -$44K – 2996
2017
Q2 		$44K Hold
2,006
– – ﹤0.01% 2004
2017
Q1 		$28K Buy
+2,006
New +$32.9K ﹤0.01% 2219

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Ameritas Investment Partners's AMRI Position: Q3 2017 in Review

Ameritas Investment Partners sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 2,006 shares — an estimated $44K sold.

Ameritas Investment Partners first reported a position in AMRI in Q1 2017 and held it in 2 quarters. The position peaked at $44K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Ameritas Investment Partners reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Ameritas Investment Partners sold 2,006 Albany Molecular Research Inc shares in Q3 2017, an estimated $44K.
  • Ameritas Investment Partners first reported a position in Albany Molecular Research Inc in Q1 2017 and held it in 2 quarters.
  • Ameritas Investment Partners's Albany Molecular Research Inc position peaked at $44K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Ameritas Investment Partners's 13F filing for Q3 2017, filed 15 Nov 2017.